HOME
市場調査レポート
医薬品受託製造サービス(CMO)および開発受託機関(CRO)の世界市場：2025年に至るCMO/CRO別予測
Pharmaceutical Contract Manufacturing & Contract Research Market By Services (CMO {API/Bulk Drugs, Advanced Drug Delivery Finished Dose Formulations}, CRO {Oncology, Vaccines, Immunology Cardiology, Neuroscience}), & Segment Forecasts, 2014 - 2025
- 出版元：Grand View Research（米国）
出版元について - 発行年：2017年5月
- 定価 Single User License(1名様ライセンス)US$4,950(米国ドル)/Multi User License(5名様)$7,950 /Enterprise License $9,950
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文 180ページになります。
- 商品コード：GRAN011
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医薬品受託製造サービス(CMO)および開発受託機関(CRO)の世界市場規模は、2016年で1231億ドルと推計されます。当レポートでは、2025年に至る医薬品受託製造サービス(CMO)及び開発受託機関(CRO)の世界市場予測(市場規模US$)、サービスタイプ別市場(CMO各種、CRO各種）、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業20社プロフィール動向などの情報も交えて、医薬品受託製造サービス(CMO)及び開発受託機関(CRO)市場の現在と今後展開を予測分析していきます。
【レポート構成概要】
◆ 医薬品受託製造サービス(CMO)及び開発受託機関(CRO)の世界市場予測2014-2025年
・市場規模(US$)
◆ サービスタイプ別、市場-2025年
受託製造（CMO）
・バルク原薬(API/Bulk Drugs)
・先進ドラックデリバリー製剤(advanced drug delivery formulations)
・パッケージング
・最終製剤
-固形製剤
-液体製剤
-半固形製剤
受託研究（CRO）
・腫瘍
・ワクチン
・炎症および免疫
・心臓病
・神経科学
・その他
（※市場規模US$）
◆主要国地域別市場-2025年
北米
・米国、カナダ
欧州
・ドイツ、英国
アジア太平洋
・インド、中国
南米
・ブラジル、メキシコ、コロンビア
・アルゼンチン、チリ、ベネズエラ
中東アフリカ
・南アフリカ
※ 国単位で全てのセグメントについての細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁)
・競合状況
◆ 医薬品受託製造サービス(CMO)及び開発受託機関(CRO)の主要企業プロフィール動向
・Boehringer Ingelheim GmbH
・Lonza
・Grifols S.A
・Jubilant Life Sciences Limited
・Pfizer, Inc. (Pfizer CenterOne)
・Charles River Laboratories International, Inc.
・Albany Molecular Research, Inc.
・Covance, Inc. (LabCorp)
・QuintilesIMS
・Baxter BioPharma Solutions
・Aenova Holding GmbH
・Vetter Pharma
・Valeant Pharmaceuticals International Inc
・Ligand Pharmaceuticals, Inc.
・Pharmaceutical Product Development, LLC
・Recipharm AB
・AbbVie, Inc
・Famar Health Care Services
・Catalent Pharma Solutions
・West Pharmaceutical Services, Inc
（全180頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Pharmaceutical Contract Manufacturing & Contract Research Market By Services (CMO {API/Bulk Drugs, Advanced Drug Delivery Finished Dose Formulations}, CRO {Oncology, Vaccines, Immunology Cardiology, Neuroscience}), & Segment Forecasts, 2014 - 2025
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Pharmaceutical Contract Manufacturing/Contract Research Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Drug shortage leading to drive demand for pharmaceutical development
3.1.1.2 Commercial success of biologics for clinical use
3.1.1.3 Lower manufacturing costs and improving economic condition of BRIC
3.1.2 Market restraint analysis
3.1.2.1 Limited outsourcing among big pharma companies’ clients
3.1.2.2 Regulatory issues pertaining to the drug approval
3.2 Penetration &Growth Prospect Mapping, 2016
3.3 Pharmaceutical Contract Manufacturing & Research Services - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Pharmaceutical Contract Manufacturing/Contract Research Market Categorization: Service Estimates & Trend Analysis
4.1 Pharmaceutical contract manufacturing & research servicesmarket: Service movement analysis
4.2 Manufacturing
4.2.1 Contract manufacturing services market, 2014 - 2025 (USD Billion)
4.2.2 API/bulk drugs
4.2.2.1 API/bulk drugs contract manufacturing market, 2014 - 2025 (USD Billion)
4.2.3 Advanced drug delivery formulations contract manufacturing
4.2.3.1 Advanced drug delivery formulations contract manufacturing services market, 2014 - 2025 (USD Billion)
4.2.4 Packaging
4.2.4.1 Packaging contract services market, 2014 - 2025 (USD Billion)
4.2.5 Finished dose formulations contract manufacturing
4.2.5.1 Finished dose formulations contract manufacturing market, 2014 - 2025 (USD Billion)
4.2.5.2 Solid finished dose formulations contract manufacturing
4.2.5.2.1 Solid finished dose formulations contract manufacturing market, 2014 - 2025 (USD Billion)
4.2.5.3 Liquid formulations
4.2.5.3.1 Liquid formulations contract manufacturing market, 2014 - 2025 (USD Billion)
4.2.5.4 Semi-solid formulations contract manufacturing
4.2.5.4.1 Semi-solid formulations contract manufacturing market, 2014 - 2025 (USD Billion)
4.3 Research
4.3.1 Research services market, 2014 - 2025 (USD Billion)
4.3.2 Oncology
4.3.2.1 Oncology market, 2014 - 2025 (USD Billion)
4.3.3 Vaccines
4.3.3.1 Vaccines market, 2014 - 2025 (USD Billion)
4.3.4 Inflammation & immunology
4.3.4.1 Inflammation & immunology market, 2014 - 2025 (USD Billion)
4.3.5 Cardiology
4.3.5.1 Cardiology market, 2014 - 2025 (USD Billion)
4.3.6 Neuroscience
4.3.6.1 Neuroscience market, 2014 - 2025 (USD Billion)
4.3.7 Other
4.3.7.1 Other research services market, 2014 - 2025 (USD Billion)
Chapter 5 Pharmaceutical Contract Manufacturing/Contract Research Market Categorization: Country Estimates & Trend Analysis, by Service
5.1 Global Pharmaceutical Contract Manufacturing/Contract Research Market Share By Country, 2016& 2025
5.2 North America
5.2.1 North America pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.2.2 U.S.
5.2.2.1 U.S. pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.2.3 Canada
5.2.3.1 Canada pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.3 Europe
5.3.1 Europe pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.3.2 Germany
5.3.2.1 Germany pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.3.3 UK
5.3.3.1 UK pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.4 Asia Pacific
5.4.1 Asia Pacific pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.4.2 India
5.4.2.1 India pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.4.3 China
5.4.3.1 China pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.5 Latin America
5.5.1 Latin America pharmaceutical contract manufacturing market, 2014 - 2025 (USD Billion)
5.5.2 Brazil
5.5.2.1 Brazil pharmaceutical contract manufacturing market, 2014 - 2025 (USD Billion)
5.5.3 Mexico
5.5.3.1 Mexico pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.5.4 Colombia
5.5.4.1 Colombia pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.5.5 Argentina
5.5.5.1 Argentina pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.5.6 Chile
5.5.6.1 Chile pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.5.7 Venezuela
5.5.7.1 Venezuela pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.6 MEA
5.6.1 MEA pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
5.6.2 South Africa
5.6.2.1 South Africa pharmaceutical contract manufacturing & research services market, 2014 - 2025 (USD Billion)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Boehringer Ingelheim GmbH
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Lonza
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Grifols S.A
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Jubilant Life Sciences Limited
6.3.4.1 Company overview
6.3.4.2 Financial Performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Pfizer, Inc. (Pfizer CenterOne)
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Charles River Laboratories International, Inc.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Albany Molecular Research, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Covance, Inc. (LabCorp)
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 QuintilesIMS
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Baxter BioPharma Solutions
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Aenova Holding GmbH
6.3.11.1 Company Overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Vetter Pharma
6.3.12.1 Company Overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Valeant Pharmaceuticals International Inc.
6.3.13.1 Company Overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.14 Ligand Pharmaceuticals, Inc.
6.3.14.1 Company Overview
6.3.14.2 Financial performance
6.3.14.3 Product benchmarking
6.3.14.4 Strategic initiatives
6.3.15 Pharmaceutical Product Development, LLC
6.3.15.1 Company Overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
6.3.15.4 Strategic initiatives
6.3.16 Recipharm AB.
6.3.16.1 Company Overview
6.3.16.2 Financial performance
6.3.16.3 Product benchmarking
6.3.16.4 Strategic initiatives
6.3.17 AbbVie, Inc.
6.3.17.1 Company Overview
6.3.17.2 Financial performance
6.3.17.3 Product benchmarking
6.3.17.4 Strategic initiatives
6.3.18 Famar Health Care Services
6.3.18.1 Company Overview
6.3.18.2 Financial performance
6.3.18.3 Product benchmarking
6.3.18.4 Strategic initiatives
6.3.19 Catalent Pharma Solutions
6.3.19.1 Company Overview
6.3.19.2 Financial performance
6.3.19.3 Product benchmarking
6.3.19.4 Strategic initiatives
6.3.20 West Pharmaceutical Services, Inc.
6.3.20.1 Company Overview
6.3.20.2 Financial performance
6.3.20.3 Product benchmarking
6.3.20.4 Strategic initiatives
List of Tables
TABLE 1 North America Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 2 North America manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 3 North America finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 4 North America research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 5 North America oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 6 U.S. Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 7 U.S. manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 8 U.S. finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 9 U.S. research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 10 U.S. oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 11 Canada Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 12 Canada manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 13 Canada finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 14 Canada research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 15 Canada oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 16 Europe Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 17 Europe manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 18 Europe finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 19 Europe research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 20 Europe oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 21 Germany Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 22 Germany manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 23 Germany finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 24 Germany research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 25 Germany. oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 26 UK Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 27 UK manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 28 UK finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 29 UK research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 30 UK oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 31 Asia Pacific Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 32 Asia Pacific manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 33 Asia Pacific finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 34 Asia Pacific research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 35 Asia Pacific oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 36 India Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 37 India manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 38 India finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 39 India research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 40 India. oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 41 China Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 42 China manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 43 China finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 44 China research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 45 China oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 46 Latin America Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 47 Latin America manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 48 Latin America finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 49 Latin America research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 50 Latin America oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 51 Brazil Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 52 Brazil manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 53 Brazil finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 54 Brazil research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 55 Brazil oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 56 Mexico Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 57 Mexico manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 58 Mexico finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 59 Mexico research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 60 Mexico oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 61 Colombia Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 62 Colombia manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 63 Colombia finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 64 Colombia research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 65 Colombia oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 66 Argentina Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 67 Argentina manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 68 Argentina finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 69 Argentina research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 70 Argentina oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 71 Chile Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 72 Chile manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 73 Chile finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 74 Chile research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 75 Chile oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 76 Venezuela Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 77 Venezuela manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 78 Venezuela finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 79 Venezuela research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 80 Venezuela oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 81 MEA Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 82 MEA manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 83 MEA finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 84 MEA research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 85 MEA oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 86 South Africa Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 87 South Africa manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 88 South Africa finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 89 South Africa research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 90 South Africa oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Factors playing role in drug shortfall
FIG. 12 Market restraint relevance analysis (current & future impact)
FIG. 13 Penetration & growth prospect mapping, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Pharmaceutical Contract Manufacturing/Contract Research:Service outlook key takeaways
FIG. 17 Top five activities by average percentage of activity outsourced
FIG. 18 Pharmaceutical Contract Manufacturing/Contract Research: Service movement analysis
FIG. 19 Survey study for outsourcing needs
FIG. 20 Contract manufacturing & research services market, 2014 - 2025 (USD Billion)
FIG. 21 API/bulk drugs contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 22 Advanced drug delivery formulations market, 2014 - 2025 (USD Billion)
FIG. 23 Packaging contract services market, 2014 - 2025 (USD Billion)
FIG. 24 Finished dose formulations market, 2014 - 2025 (USD Billion)
FIG. 25 Solid finished dose formulations contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 26 Liquid formulations contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 27 Semi-solid formulations contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 28 Contract research services market, 2014 - 2025 (USD Billion)
FIG. 29 Oncology market, 2014 - 2025 (USD Billion)
FIG. 30 Breakdown of vaccines on the basis of availability
FIG. 31 Vaccines market, 2014 - 2025 (USD Billion)
FIG. 32 Inflammation & immunology market, 2014 - 2025 (USD Billion)
FIG. 33 Cardiology market, 2014 - 2025 (USD Billion)
FIG. 34 Neuroscience market, 2014 - 2025 (USD Billion)
FIG. 35 Other research services market, 2014 - 2025 (USD Billion)
FIG. 36 Regional market place: Key takeaway
FIG. 37 Global Pharmaceutical Contract Manufacturing/Contract Research country outlook, 2016 & 2025
FIG. 38 North America Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 39 U.S. Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 40 Canada Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 41 Europe Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 42 Germany Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 43 UK Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 44 Asia Pacific Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 45 India Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 46 China Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 47 Latin America Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 48 Brazil Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 49 Mexico Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 50 Colombia Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 51 Argentina Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 52 Chile Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 53 Venezuela Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 54 MEA Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 55 South Africa Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 56 Strategy framework
FIG. 57 Participant categorization
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。
リサーチカテゴリ一覧
スマートグリッド
血液検査製品・サービスの世界市場：技術別、製品サービス別2021年予測
お問合わせはこちらから
